跳至主要内容
临床试验/NCT02759926
NCT02759926Unknown不适用

The Role of Bitter Taste Receptors Expressed in the Gastrointestinal Tract in Altering Food Intake and Gastrointestinal Motility

Universitaire Ziekenhuizen KU Leuven0 个研究点目标入组 98 人开始时间: 2011年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
98
主要终点
Change in gastrointestinal motility measured by antroduodenal high-resolution manometry

研究概览

简要总结

In this study, the investigators aimed at evaluating the role of bitter taste receptors in the gastrointestinal tract (GIT). Intragastric or intraduodenal administration of denatonium benzoate (DB) or quinine hydrochloride were compared with placebo administration for their effects on lingual sensitivity, gastrointestinal motility (both in the fasted and fed state), gut hormone release (motilin, ghrelin, glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK)) and food intake. Differences between lean and obese subjects will be evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • BMI>30 kg/m² for the obese volunteers
  • BMI<30 kg/m² for the lean volunteers
  • Subject is capable and willing to give informed consent
  • Female volunteers of child bearing potential must use oral, injected or implanted hormonal methods of contraception

排除标准

  • Female volunteer is pregnant or breastfeeding
  • Gastrointestinal diseases, major abdominal surgery
  • Major psychiatric illnesses
  • Volunteers that use drugs affecting the GIT or the central nervous system (CNS)
  • Volunteers that suffer from diabetes mellitus
  • Volunteers suffering from an endocrine disease such as diabetes, Cushing's disease, Addison's disease, hypothalamic tumor...
  • Volunteers that have undergone surgical procedure for weight loss

研究组 & 干预措施

Denatonium benzoate intragastric

Active Comparator

1 µmol/kg bodyweight (10mM) was administered as a bolus into the stomach through a nasogastric feeding tube.

干预措施: Denatonium benzoate (Drug)

Quinine hydrochloride intragastric

Active Comparator

10 µmol/kg bodyweight (100mM) was administered as a bolus into the stomach through a nasogastric feeding tube.

干预措施: Quinine hydrochloride (Drug)

Tap water intragastric

Placebo Comparator

An equal amount of tap water was administered as a bolus into the stomach through a nasogastric feeding tube.

干预措施: Tap water (Drug)

Denatonium benzoate intraduodenal

Active Comparator

1 µmol/kg bodyweight (10mM) was administered as a bolus into the proximal part of the duodenum through a nasogastric feeding tube.

干预措施: Denatonium benzoate (Drug)

Quinine hydrochloride intraduodenal

Active Comparator

10 µmol/kg bodyweight (100mM) was administered as a bolus into the proximal part of the duodenum through a nasogastric feeding tube.

干预措施: Quinine hydrochloride (Drug)

Tap water intraduodenal

Placebo Comparator

An equal amount of tap water was administered as a bolus into the proximal part of the duodenum through a nasogastric feeding tube.

干预措施: Tap water (Drug)

结局指标

主要结局

Change in gastrointestinal motility measured by antroduodenal high-resolution manometry

时间窗: 2 hours after administration, continuous measurement with high resolution manometry

次要结局

  • Change in gut hormone release measured by specific radioactive immunoassays(2 hours after administration, blood sample every 10 min)
  • Change in food intake measured by the caloric content of the meal(ad libitum food intake for 1 hour, 40 min after administration)
  • Change in subjective hunger and satiety scores measured by visual analogue scales of 100 mm(2 hours after administration, assessment every 5 min)

研究者

申办方类型
Other
责任方
Sponsor

相似试验